Latest Shareholder Value News

Opthea has successfully settled its Development Funding Agreement, avoiding a potential $680 million liability and securing $20 million in cash. Leadership changes include the CEO and CFO stepping down, with the Chairman assuming CEO duties.

Woodside Energy Group reported robust first-half results in 2025, with production reaching 548 Mboe/d and a net profit after tax of $1.3 billion, while progressing key LNG projects and declaring a fully franked interim dividend.

Gorilla Gold reports exceptional high-grade gold intercepts from step-out drilling at its Sovereign deposit, significantly extending mineralisation down-dip and along strike. This breakthrough sets the stage for a major resource upgrade at the Comet Vale Project later this year.

BHP Group Limited reported strong FY2025 financial results driven by record copper production and operational excellence, while advancing key growth projects and sustainability goals. The company maintained its dividend payout and navigated cost escalations at the Jansen potash project alongside ongoing Samarco dam failure remediation.

HUB24 Limited has reported a standout FY25 with robust revenue growth, record net inflows, and a significant dividend increase, reinforcing its leadership in Australia's wealth management platform sector.

SRG Global has delivered record financial results for FY25, marked by strong revenue growth and a transition to net cash, while setting an optimistic profit guidance for FY26.

Monadelphous Group Limited reported a robust 12% revenue increase to $2.27 billion and a 35% rise in net profit, driven by strong demand across resources and energy sectors and a record $2.5 billion in new contracts.

HUB24 Limited has announced a fully franked ordinary dividend of AUD 0.32 per share for the six months ending June 2025, signaling steady shareholder returns ahead of the payment date in October.

HUB24 Limited reported robust FY25 results with revenue climbing 24% to $406.6 million and underlying net profit after tax soaring 44%. The company’s platform funds under administration grew 34%, underpinning a 47% increase in fully franked dividends.

CSL Limited reported solid FY25 financials with 5% revenue growth and announced a strategic transformation including a $500 million annual cost saving target and plans to spin off its vaccine business, CSL Seqirus, as a separate ASX-listed entity.

CSL Limited reported robust FY25 results alongside a sweeping strategic overhaul, including a major cost-saving program and plans to spin off its vaccine unit CSL Seqirus as a standalone ASX-listed company.

CSL Limited posted a 14% rise in net profit for FY2025, underpinned by strong immunoglobulin sales and new product launches, while announcing plans to demerge its vaccines business, CSL Seqirus, to sharpen strategic focus.